🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
The trial is looking for new and better ways to treat melanoma, an aggressi...
Status
Terminated
Location
The Christie NHS Foundation Trust
Start Date
2021-11-08
Trial ID
NCT04901988
Treatments Being Tested
This clinical trial is to clarify whether treatment with a checkpoint inhib...
Status
Recruiting
Location
Herlev Universityhospital
Start Date
2018-06-06
Trial ID
NCT03563729
This is a multi-site, three-cohort phase II trial of cabozantinib for IMDC ...
Status
Recruiting
Location
Fox Chase Cancer Center
Start Date
2022-01-21
Trial ID
NCT05263050
Treatments Being Tested
Pancreatic cancer (PC) remains a dreadful disease due to its often advanced...
Status
Terminated
Location
Herlev & Gentofte University Hospital, Denmark
Start Date
2020-04-16
Trial ID
NCT04258150
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of ne...
Status
Active Not Recruiting
Location
Sidney Kimmel Comprehensive Cancer Center
Start Date
2021-05-28
Trial ID
NCT04658147
Treatments Being Tested
This is a Phase 2 study designed to evaluate the combination of checkpoint ...
Status
Completed
Location
University of Minnesota Masonic Cancer Center
Start Date
2019-05-28
Trial ID
NCT03850691
Melanoma remains a common cancer with rising incidence, and despite signifi...
Status
Not Yet Recruiting
Location
HFR Fribourg
Start Date
2026-09
Trial ID
NCT07574047
Treatments Being Tested
The study will evaluate the clinical activity of PD-(L)1 Checkpoint Inhibit...
Status
Terminated
Location
The University of Arizona Cancer Center
Start Date
2018-09-11
Trial ID
NCT03606174
Treatments Being Tested
To determine the feasibility and safety of administering a regimen of TIL/I...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2018-02-06
Trial ID
NCT03526185
Treatments Being Tested